Enhancing Antibody Therapeutics Through Precision Glycoengineering Antibody therapeutics, particularly monoclonal antibodies (mAbs), have revolutionized the treatment of various diseases, including cancer, autoimmune disorders, and infectious diseases. However, the efficacy of these therapeutics can be significantly influenced by their glycosylation patterns—the addition of sugar moieties to the antibody structure. Precision glycoengineering, the targeted modification of these […]